2020
DOI: 10.1016/j.otsr.2019.12.024
|View full text |Cite
|
Sign up to set email alerts
|

Percutaneous alcohol-based sclerotherapy in aneurysmal bone cyst in children and adolescents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 22 publications
0
6
1
Order By: Relevance
“…Age under 10, gender, involvement of the lower extremities, or lesions adjacent to open growth plates have all been suggested as possible risk factors for local recurrence after surgical intervention in the treatment of an ABC 21,26 . Our results show that patients under the age of 10 and females tend to have a higher local recurrence rate, but these findings were not statistically significant.…”
Section: Discussioncontrasting
confidence: 62%
“…Age under 10, gender, involvement of the lower extremities, or lesions adjacent to open growth plates have all been suggested as possible risk factors for local recurrence after surgical intervention in the treatment of an ABC 21,26 . Our results show that patients under the age of 10 and females tend to have a higher local recurrence rate, but these findings were not statistically significant.…”
Section: Discussioncontrasting
confidence: 62%
“…Percutaneous alcohol sclerotherapy is effective for the treatment of ABC in children, but the size, invasiveness, location, and age of the patients should be considered. [ 14 ] Li [ 15 ] reported a 57-year-old patient with a giant ABC secondary to a giant cell tumor of the finger bone who was finally treated with amputation of the fifth finger. Denosumab seems to be effective in relieving pain and improving nerves in ABCs, but it does not significantly reduce the actual recurrence rate and has potentially life-threatening side effects.…”
Section: Discussionmentioning
confidence: 99%
“…[ 23 , 29 , 30 ] In a larger case series, Rastogi et al observed a lesion size reduction of 76.6% after a mean of 3 injections in 72 patients with ABCs treated with polidocanol [ 31 ], while Marie-Hardy et al reported a lesion size reduction in 85% in 55 ABCs treated with 96% ethanol in a mean of 1.7 injections. [ 32 ] We think that additional cavity reconstruction using injectable bone void fillers may be of particular benefit for minimally invasive treatments of recurrent benign bone lesions to further promote bone healing.…”
Section: Revisions After Surgical Treatmentmentioning
confidence: 99%